BIOAVAILABILITY MONOGRAPH - PHENYLBUTAZONE

被引：7

作者：

DISANTO, AR ^{[1
]}

机构：

[1] UPJOHN CO,KALAMAZOO,MI 49001

来源：

JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION | 1976年 / 16卷 / 06期

关键词：

D O I：

10.1016/S0003-0465(16)33630-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：365 / 367

页数：3

共 21 条

[1] DRUG-METABOLISM IN NORMAL CHILDREN, LEAD-POISONED CHILDREN, AND NORMAL ADULTS [J].

ALVARES, AP ;

KAPELNER, S ;

SASSA, S ;

KAPPAS, A .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) :179-183

[2]

BURNS JJ, 1953, J PHARMACOL EXP THER, V109, P346

[3]

BURNS JJ, 1955, J PHARMACOL EXP THER, V113, P481

[4]

Fuchs W, 1965, Munch Med Wochenschr, V107, P1267

[5]

GLADTKE E, 1968, FARMACO-ED SCI, V23, P897

[6]

GOODMAN LS, 1970, PHARMACOL BASIS THER, P335

[7] A STUDY OF THE INVERSE RELATIONSHIP BETWEEN PKA AND RATE OF RENAL EXCRETION OF PHENYLBUTAZONE ANALOGS IN MAN AND DOG [J].

GUTMAN, AB ;

DAYTON, PG ;

YU, TF ;

BERGER, L ;

CHEN, W ;

SICAM, LE ;

BURNS, JJ .

AMERICAN JOURNAL OF MEDICINE, 1960, 29 (06) :1017-1033

[8]

HERRMANN B, 1960, MED EXP, V1, P1970

[9]

LEESON LJ, 1972, 1971 P C BIOAV DRUGS, P154

[10]

MCGILVER.IJ, 1973, PHARMACOLOGIST, V15, P213

← 1 2 3 →